LOL, I think this was a very good weekend for EXEL at ESMO. Zelboraf+MEK moving directly from P1b to Phase 3, and the CRPC results at 40mg are looking pretty darn good.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.